Human tissue kallikreins: a family of new cancer biomarkers - PubMed

Affiliations

• PMID: 12142373

Review

Human tissue kallikreins: a family of new cancer biomarkers

Eleftherios P Diamandis et al. Clin Chem. 2002 Aug.

Abstract

Kallikreins are a subgroup of the serine protease enzyme family. Until recently, it was thought that the human kallikrein gene family contained only three members. In the past 3 years, the entire human kallikrein gene locus was discovered and found to contain 15 kallikrein genes. Kallikreins are expressed in many tissues, including steroid hormone-producing or hormone-dependent tissues such as the prostate, breast, ovary, and testis. Most, if not all, kallikreins are regulated by steroid hormones in cancer cell lines. There is strong but circumstantial evidence linking kallikreins and cancer. Prostate-specific antigen (PSA; hK3) and, more recently, human glandular kallikrein (hK2) are widely used tumor markers for prostate cancer. Three other kallikreins, hK6, hK10, and hK11, are emerging new serum biomarkers for ovarian and prostate cancer diagnosis and prognosis. Several other kallikreins are differentially expressed at both the mRNA and protein levels in various endocrine-related malignancies, and they have prognostic value. The coexpression of many kallikreins in the same tissues (healthy and malignant) points to the possible involvement of kallikreins in cascade enzymatic pathways. In addition to their diagnostic/prognostic potential, kallikreins may also emerge as attractive targets for therapeutics.

Similar articles

• Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

  Yousef GM, Diamandis EP. Yousef GM, et al. Tumour Biol. 2002 May-Jun;23(3):185-92. doi: 10.1159/000064027. Tumour Biol. 2002. PMID: 12218299 Review.

• Human tissue kallikrein gene family: applications in cancer.

  Obiezu CV, Diamandis EP. Obiezu CV, et al. Cancer Lett. 2005 Jun 16;224(1):1-22. doi: 10.1016/j.canlet.2004.09.024. Cancer Lett. 2005. PMID: 15911097 Review.

• Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.

  Sauter ER, Lininger J, Magklara A, Hewett JE, Diamandis EP. Sauter ER, et al. Int J Cancer. 2004 Feb 10;108(4):588-91. doi: 10.1002/ijc.11607. Int J Cancer. 2004. PMID: 14696124

• An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers.

  Yousef GM, Diamandis EP. Yousef GM, et al. Clin Biochem. 2003 Sep;36(6):443-52. doi: 10.1016/s0009-9120(03)00055-9. Clin Biochem. 2003. PMID: 12951170 Review.

• The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.

  Clements JA, Willemsen NM, Myers SA, Dong Y. Clements JA, et al. Crit Rev Clin Lab Sci. 2004;41(3):265-312. doi: 10.1080/10408360490471931. Crit Rev Clin Lab Sci. 2004. PMID: 15307634 Review.

Cited by

• B1 but not B2 bradykinin receptor agonists promote DU145 prostate cancer cell proliferation and migration.

  Naidu N, Botha JH, Naidoo S. Naidu N, et al. Afr Health Sci. 2014 Sep;14(3):657-62. doi: 10.4314/ahs.v14i3.22. Afr Health Sci. 2014. PMID: 25352885 Free PMC article.

• Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma.

  Abuduhadeer X, Xu X, Aihesan K, Yilihamu M, Zhao Y, Zhang W. Abuduhadeer X, et al. J Clin Lab Anal. 2021 Oct;35(10):e23958. doi: 10.1002/jcla.23958. Epub 2021 Sep 12. J Clin Lab Anal. 2021. PMID: 34510543 Free PMC article.

• Clinical significance of human kallikrein 12 gene expression in gastric cancer.

  Zhao EH, Shen ZY, Liu H, Jin X, Cao H. Zhao EH, et al. World J Gastroenterol. 2012 Dec 7;18(45):6597-604. doi: 10.3748/wjg.v18.i45.6597. World J Gastroenterol. 2012. PMID: 23236234 Free PMC article.

• Serum human kallikrein 7 represents a new marker for cervical cancer.

  Li W, Zhao Y, Ren L, Wu X. Li W, et al. Med Oncol. 2014 Oct;31(10):208. doi: 10.1007/s12032-014-0208-0. Epub 2014 Sep 3. Med Oncol. 2014. PMID: 25182706 Clinical Trial.

• Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.

  Santin AD, Zhan F, Cane' S, Bellone S, Palmieri M, Thomas M, Burnett A, Roman JJ, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Br J Cancer. 2005 Apr 25;92(8):1561-73. doi: 10.1038/sj.bjc.6602480. Br J Cancer. 2005. PMID: 15785748 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal